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ABSTRACT A cell-free protein-synthesizing system has
been reconstituted using the S-30 fraction or ribosomes and the
S-100 fraction from Plasmodiumfalckarum. Addition of heme
in vitro stimulates cell-free protein synthesis strikingly. Chlo-
roquine inhibits the heme-dependent protein synthesis in the
parasite lysate. The drug has also been found to inhibit parasite
protein synthesis in situ at therapeutic concentrations soon
after addition to parasite cultures. Ribosomes as well as the
S-100 fraction isolated from such chloroquine-treated cultures
are defective in protein synthesis. Addition of hemin plus
glucose 6-phosphate or high concentrations of GTP, cAMP,
and an active preparation of eIF-2 to the parasite cell-free
system restores protein synthesis to a sigfant extent in
chloroquine-treated cultures. Under conditions of inhibition of
protein synthesis in situ by chloroquine in the culture, the
parasite eukaryotic initiation factor 2a- (eIF-2a) is phospho-
rylated in the parasite lysate to a greater extent than that
observed in the control culture. Addition of hemin in vitro
suppresses this phosphorylation. eIF-2a kinase activity is pres-
ent in the parasite lysate and is not a contaminant derived from
the human erythrocytes used to culture the parasite. The
heme-chloroquine interactive effects can also be demonstrated
with purified eIF-2a kinase from rabbit reticulocyte lysate. It
is proposed that chloroquine inhibits heme-dependent protein
synthesis in the parasite and this is an early evefit mediating the
growth-inhibitory effects of the drug.
It is rather surprising that the mechanism of action of
chloroquine, a widely used antimalarial drug, is not fully
understood. An early suggestion based on intercalation of
chloroquine with DNA and inhibition ofDNA synthesis (1, 2)
has not found favor in view of the millimolar concentrations
required for the purpose, whereas nanomolar concentrations
in the culture are growth inhibitory. There has, however,
been a recent attempt to revive this theory (3, 4). Chloroquine
is known to accumulate in the acid vesicles ofthe parasite and
increase the pH and osmolality of the vesicles, leading to
swelling and membrane leakiness (5). However, it has also
been suggested that alkalinization ofthe vesicles per se is not
adequate to explain the toxicity of chloroquine, and substan-
tial alkalinization does not occur within the therapeutic drug
concentration range (6). It is known that intraerythrocytic
Plasmodium digests up to 75% of the host cell hemoglobin in
the acid food vacuoles, and the generated heme is present as
an inert complex referred to as malaria pigment or hemozoin
(7). Chloroquine has been demonstrated to bind to ferripro-
toporphyrin IX with high affinity in vitro and in situ, and it has
been suggested that the drug can sequester heme, interfering
with the formation of the inert pigment, and the complex can
lyse the parasite membrane (7-9). However, there have been
arguments against this theory (3, 6).
Heme is required for protein synthesis in the reticulocyte
lysate (10, 11) and a few nonerythroid systems as well (12).
We have investigated the possibility whether chloroquine can
inhibit the translation process of the parasite by virtue of
complex formation with heme, if the parasite protein syn-
thesis were to be heme dependent. Earlier, the protein
synthesis rates obtained with Plasmodia infecting birds and
animals were low, and it was generally concluded that
chloroquine is not a potent inhibitor of protein synthesis (13,
14). In the present study we demonstrate that an early event
in chloroquine action is an inhibition of heme-dependent
protein synthesis in the parasite.
MATERIALS AND METHODS
Maintenance of the Malarial Parasite. Plasmodium falci-
parum FCK 2 strain, a local isolate from Karnataka State,
India, was cultured in human O-positive washed erythrocytes
in vitro using standard techniques (15).
Synchronization of Parasites in Culture. Parasites were
synchronized using 5% D-sorbitol (16) and the cultures were
pooled at late trophozoite stage with 12-15% parasitaemia.
Parasites were released from the erythrocytes with 0.15%
saponin (17).
Preparation of the Parasite S-30 Fraction, Isolation of Ri-
bosomes, and Constitution of the Cell-Free System. The free
parasites were lysed with 4 vol ofice-cold lysing solution [100
mM KCI/7 mM Mg(OAc)2/380 mM sucrose/6.5 mM 2-mer-
captoethanol/50 mM Tris HCl, pH 7.4/0.14% (vol/vol) Tri-
ton X-100] as described for Plasmodium knowlesi (18). Leu-
peptin (15 gM) and placental ribonuclease inhibitor (20 units)
were added to the free parasites before adding lysing solu-
tion. The suspension was then centrifuged at 12,000 x g for
20 min at 40C. The supernatant was passed through a G-50
spun column and used as the S-30 fraction. The 12,000 x g
supernatant was centrifuged twice at 10,000 x g for 10 min
and the second 10,000 x g supernatant was centrifuged at
105,000 x g for 60 min at 40C to sediment ribosomes. The
ribosomal pellet was rinsed with 200 p.l of buffer A [0.25 M
sucrose/25 mM KCI/5 mM Mg(OAc)2/50 mM Tris-HCI, pH
7.4] and resuspended in the same buffer. The postribosomal
supernatant was passed through a G-50 spun column and
used as the S-100 fraction. Cell-free protein synthesis was
carried out in 50 ILI containing 20 mM Hepes (pH 7.5), 1 mM
ATP, 0.1 mM GTP, 5 mM creatine phosphate, 45 units of
creatine phosphokinase per ml, 0.5 mM glucose 6- phosphate,
7 mM Mg(OAc)2, 110 mM potassium acetate, 0.375 mM
spermidine, 2.5 mM dithiothreitol, 2 pug ofwheat germ tRNA,
40 p.M (each) of 19 amino acids except methionine (20 p.Ci,
800 Ci/mmol; 1 Ci = 37 GBq; Amersham), and the S-30
Abbreviations: eIF-2, eukaryotic initiation factor 2; eIF-2a, a sub-
unit (38 kDa) of eIF-2; HRI, heme-regulated inhibitor.
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fraction or S-100 plus ribosomes (10 Ag of rRNA). Hemin,
when added, was at 15 ,uM concentration. Chloroquine
phosphate and hemin solutions were prepared fresh and were
preincubated together on ice for 5 min before the addition of
other components. Reactions were initiated with the addition
of the S-30 fraction or ribosomes and incubated at 30'C,
samples (5 p.1) were spotted onto Whatman 1MM filter discs,
and radioactivity was measured after washing with trichloro-
acetic acid (12). All assays were run in triplicate and zero time
values were subtracted.
Preparation of Reticulocyte Lysate and Cell-Free Protein
Synthesis. Reticulocyte lysate was prepared and cell-free
protein synthesis with [35S]methionine was carried out in 25
A.l using standard protocols (10, 12).
Phosphorylation of Proteins in Reticulocyte and Parasite
Lysate and NaDodSO4/PAGE. Phosphorylation of the para-
site eukaryotic initiation factor 2a- (eIF-2a) was assessed in
the parasite lysate prepared from in situ chloroquine-treated
and control cultures. Reaction mixtures were the same as that
for protein synthesis except that unlabeled ATP was replaced
with [y-32PJATP (25 p.Ci, 3000 Ci/mmol; Amersham) and
[35S]methionine was omitted. The protein synthesis mixture
(50 1.l) was incubated at 300C for 5 min before [y32P]ATP
addition. Samples (5 ,ul) were removed 2 min after 32p
addition and mixed with equal volumes of NaDodSO4/
protein dissociation buffer. These samples were analyzed on
10o polyacrylamide gels (0.1% NaDodSO4; bisacrylamide-
:acrylamide ratio, 1:38.5), stained with Coomassie blue, and
subjected to autoradiography (19). The rest ofthe sample was
processed for immunoprecipitation. Similar phosphorylation
experiments were also carried out with the rabbit reticulocyte
lysate.
Immunoprecipitation of Parasite eIF-2a. Samples (2 X 10
cpm) were boiled for 3 min in 2% NaDodSO4 sample buffer,
diluted 1:10 with buffer containing 1% Triton X-100, 50 mM
Tris HCI (pH 7.4), 150 mM NaCI, and 5 mM EDTA, and
mixed with 2 ,ul of rabbit reticulocyte eIF-2 antiserum.
Treatment with Staphylococcus aureus cells, washing, and
extraction were carried out as described by Maccecchini et
al. (20). The S. aureus cells were removed by centrifugation
and the supernatant was subjected to NaDodSO4/l0oPAGE
and autoradiography.
Effect of Chloroquine in Situ on Protein Synthesis by the
Metabolic Labeling of Parasites with [3S]Methionine. Parasite
cultures (late trophozoites) were incubated at 37°C with or
without chloroquine (3 ,uM) for 30 min and then [35S]methio-
nine (180 ,uCi/ml of culture) was added to the cultures. After
30 min of labeling, the free parasite pellet was washed three
times with excess phosphate-buffered saline, solubilized in 4
vol of buffer containing 50 mM Tris-HCl (pH 8.0), 5 mM
EDTA, 5 mM EGTA, 5 mM iodoacetamide, 1 mM phenyl-
methylsulfonyl fluoride, and 1% (vol/vol) Nonidet P-40, and
centrifuged. The parasite proteins in 20 ,ul of the supernatant
were precipitated with 10o trichloroacetic acid. The precip-
itate was solubilized in 2% NaDodSO4 buffer and subjected
to NaDodSO4/PAGE followed by fluorography. The amount
of protein loaded in each lane was 140 ,ug.
Effect of Hemin and Chloroquine in Vitro on Heme-
Regulated Inhibitor (HRI) Activity. HRI was purified from
reticulocytes and assayed for autophosphorylation as well as
eIF-2a kinase activities as described by Chen et al. (21).
Protein kinase assays (20 ,ul) contained 20 mM Tris HCI (pH
7.7), 2mM Mg(OAC)2, 40-60mM KCI, 25-50xM [y32P]ATP
(20-30 Ci/mmol), and HRI preparation (50-100 ng). For the
eIF-2a kinase assay, 0.5 ,ug of rabbit reticulocyte eIF-2 was
included (21). Chloroquine and hemin were added at 5and 10
p.M concentrations. The reactions were initiated by the
addition of [y-32PJATP and incubation was at 300C for 10 min.
The reactions were terminated by the addition of NaDodSO4
denaturing buffer and analyzed by NaDodSO4/PAGE and
autoradiography.
RESULTS
Chloroquine Inhibits Heme-Dependent Protein Synthesis in
Rabbit Reticulocyte Lysate. The reticulocyte lysate used was
stimulated 3-fold with 20 p.M hemin during a 30-min incuba-
tion period. The response to hemin added 10 min after the
start of incubation was found to be decreased by 50%.
Chloroquine at a concentration of 10 p.M blocked the heme-
mediated stimulation by 80% (Fig. 1). Higher concentrations
of chloroquine did not lead to any significant increase in the
extent of inhibition obtained. Again, chloroquine at these
concentrations did not inhibit the basal protein synthesis
obtained in the absence of added hemin.
Heme Stimulates Protein Synthesis in Parasite Lysate and
Chloroquine Inhibits This Process. Addition of heme (15 p.M)
to the parasite lysate (S-30) resulted ir. stimulation of parasite
protein synthesis by 3-fold (Fig. 2). The effect of a range of
heme concentrations was tested and 15 pM was found to be
optimal. Chloroquine at 8 p.M was found to strikingly inhibit
the heme-dependent increase in protein synthesis. An in-
crease in chloroquine concentration to 16 p.M only marginally
increases the extent of inhibition. At these chloroquine
concentrations, protein synthesis in the absence of added
heme is not inhibited by more than 15% (data not presented).
Chloroquine Inhibits Protein Synthesis in P. falciparum in
Situ. In one set of experiments, [35S]methionine was added to
in situ chloroquine-treated cultures and incorporation into
the parasite proteins was measured. [35S]Methionine incor-
poration in parasite proteins measured over a 30-min labeling
period is inhibited by 50-60%o in the drug-treated cultures
(control cultures, 47,484 cpm/mg of protein; chloroquine-
treated cultures, 17,472 cpm/mg of protein). The autoradio-
gram (Fig. 3A) and the densitometric scan (Fig. 3B) indicate
that the inhibition is generalized as would be the case if the
translation process is interfered with. Similar results were
obtained when chloroquine was added in situ at a concen-
tration of 0.3 puM to the cultures (data not presented). In the
second set, ribosomes and S-100 fraction were prepared from
control and chloroquine-treated cultures (3 p.M chloroquine
Time, min
FIG. 1. Inhibition of heme-dependent protein synthesis by chlo-
roquine in rabbit reticulocyte lysate. Protein synthesis was assayed
as described in the text. The reaction mixtures (25 1.l), which
contained the following, were incubated at 30TC and processed: 20
p.M hemin added at 0 min (-); 20 p.M hemin added at 10 min (A); 20
A.M hemin plus 10NAM chloroquine added at 0 min (A); no additions
(0).
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FIG. 2. Inhibition of heme-dependent protein synthesis by chlo-
roquine in parasite lysates. Protein synthesis was assayed as de-
scribed in the text. The parasite S-30 preparation and other compo-
nents (50,l), which contained the following, were incubated at 30°C
and processed: 15,uM hemin added at 0 min (e); 15 ,uM hemin added
at 8 min (A); 15 ,uM hemin plus 8 AM chloroquine added at 0 min ();
no additions (o).
for 30 min) and cell-free protein synthesis was assessed in
mixed preparations. Maximum inhibition in [35S]methionine
incorporation is seen when the ribosomes and S-100 fraction
are from chloroquine-treated cultures, indicating that these
fractions are defective in supporting protein synthesis (Table
1).
Reversal of in Situ Chloroquine Effects in Cell-Free Parasite
Protein Synthesis. The effects of added hemin plus glucose
6-phosphate or high concentrations of GTP, cAMP, and the
active eIF-2 preparation (from reticulocytes) were examined
in the cell-free system prepared from control and chloro-
quine-treated cultures, since it has been reported that these
compounds can individually counteract the inhibited protein
synthesis in heme-deficient reticulocyte lysates (22-24). Ad-
dition ofhemin plus glucose 6-phosphate, GTP, cAMP, or the
active preparation of eIF-2 to the cell-free system prepared
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FIG. 3. Effect of chloroquine in situ on [35S]methionine incor-
poration into total proteins of the parasite. The incorporation of
[35S]methionine into parasite proteins was determined by analyzing
samples from control and chloroquine-treated cultures on Na-
DodSO4/7.5% PAGE followed by fluorography. (A) Autoradiogram
of parasite proteins obtained-from normal (lane 1) and chloroquine-
treated (lane 2) cultures. Molecular mass is indicated in kDa. (B)
Densitometric scan of lanes 1 and 2 shown in A. The autoradiogram
was scanned with an LKB 22002 Ultra Scan laser densitometer.
Table 1. Cell-free protein synthesis with control and in situ
chloroquine-treated P. falciparum cultures
[35S]Methionine incorporation
into proteins, cpm x 10-3 per
Addition 10 ,ug of rRNA
Ribosome (C)
+ S100 (C) 163.0
+ S100 (CQ) 111.8
Ribosome (CQ)
+ S100 (C) 78.6
+ S100 (CQ) 69.6
Cultures were incubated with chloroquine (3 tuM) for 30 min.
Parasite ribosomes and S-100 fractions from control (C) and chlo-
roquine-treated (CQ) cultures were prepared and cell-free protein
synthesis was carried out as described in text.
from chloroquine-treated cultures is able to counteract the
inhibited protein synthesis to a significant extent (Table 2)..
Chloroquine-Treated Parasite Culture Shows Enhanced
eIF-2a Phosphorylation in the Cefl-FreeSystem. It is well
established that heme deficiency leads to phosphorylation of
the initiation factor subunit eIF-2a by HRI, and this results
in the inhibition of protein synthesis in reticulocyte lysates
(22). Addition of chloroquine in vitro to reticulQcyte lysate
does result in enhanced phosphorylation of a band that
comigrates with purified rabbit reticulocyte eIF-2a, over-
coming the suppressive effects ofadded hemin (Fig. 4). Next,
the phosphorylation reaction was carried out in parasite
lysate (S-30) prepared from normal and chloroquine-treated
P. falciparum cultures and the products were analyzed by
NaDodSO4/PAGE and autoradiography. The band corre-
sponding to a 38-kDa protein and comigrating with the
purified rabbit reticulocyte eIF-2a shows a higher level of
phosphorylation in the cell-free system prepared from chlo-
roquine-treated cultures than control. Addition of hemin in
vitro inhibits phosphorylation of this protein (Fig. 5A). An
additional band with a molecular mass of 33 kDa also shows
some increase in phosphorylation in chloroquine-treated
cultures, which is inhibited by the addition of hemin in vitro.
However, the identity of this band is not clear. Quantitative
immunoprecipitation analysis also reveals that the parasite
eIF-2a in in situ chloroquine-treated cultures is phosphoryl-
ated to a greater extent than that from control cultures in the
cell-free system (Fig. 5 B and C). This phosphorylation is
significantly decreased in the presence of hemin. The eIF-2
polyclonal antibody picks up two other strongly labeled
Table 2. Counteraction of the effects of chloroquine-mediated
heme deficiency on cell-free protein synthesis in
P. falciparum cultures
[35S]Methionine incorporation
into proteins, cpm x 10- per
10 s~g of rRNA
Control CQ treated
Addition 10 min 20 min 10 min 20 min
Basal (no addition) 124.2 162.0 62.4 78.6
Hemin, 20 IM 163.2 292.4 101.2 146.2
+ Glc-6-P 326.4 505.2 247.0 324.2
Hemin, 5 ,uM
+ Glc-6-P 151.2 186.2 79.2 89.8
+ Glc-6-P + cAMP 273.0 452.2 240.6 313.0
+ Glc-6-P + GTP 285.0 478.4 231.2 304.2
eIF-2 + Glc-6-P 264.2 424.8 180.0 231.2
Glc-6-P, glucose 6-phosphate; CQ, chloroquine. The S-30 fraction
was used for protein synthesis. Glc-6-P was added at a concentration
of 500 1M; GTP and cAMP were added at concentrations of 2 mM
and 10 mM, respectively. The rabbit reticulocyte eIF-2 (5 ,ug) used
contained a, .8, and y subunits and the 67-kDa protein.
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30 eIF-2a phosphorylation in reticulo-
cyte lysate. Lane 1, control (no addi-
tion); lane 2, 10 AM chloroquine plus
20 uM hemin; lane 3, 20 uM hemin.
Purified eIF-2 and molecular mass
markers (given in kDa) were run on
separate slots and their migration po-
u' _i"" sitions are indicated.
bands, which could be the p and y subunits, and a few other
minor bands. However, none of the bands picked up by the
antibody, other than eIF-2a, shows increased phosphoryla-
tion in cell-free extracts prepared from chloroquine-treated
cultures.
eIF-2a Kinase Activity Is of Parasitic Origin. Attempts to
detect HRI in parasite S-30 lysates using a monoclonal
antibody against rabbit reticulocyte HRI were not successful.
However, this monoclonal antibody is known to be specific
to rabbit reticulocyte HRI and does not even react with
human HRI (J.-J. Chen and I. M. London, personal commu-
nication). But a significant level of phosphorylation of the
parasite ribosomal proteins can be detected only with the
parasite S-100 preparation (Fig. 6A). Significant phosphory-
lation of any of the parasite ribosomal proteins over endog-
enous levels (ribosomes in the absence of parasite S-100 or
erythrocyte lysate) cannot be detected with the human eryth-
rocyte lysate prepared from the culture except for the phos-
phorylation of a high molecular mass protein band. The final
wash of the parasite pellet also does not have any detectable
phosphorylating activity. It is also known that there is little
or no detectable HRI activity present in mature erythrocyte
(25). In addition, the parasite S-100 preparation, when incu-
bated with purified reticulocyte eIF-2 preparation, is able to
phosphorylate a specific band corresponding to eIF-2a (Fig.
6B).
Effects of Chloroquine and Hemin in Vitro on Purified
Rabbit Reticulocyte HRI Activity. It was of interest to exam-
ine whether chloroquine would have any effect on purified
HRI activity in vitro. This cyclic AMP-independent protein
kinase specifically phosphorylates eIF-2a and also undergoes
autophosphorylation (26). J.-J. Chen and I. M. London (per-
sonal communication) carried out the experiments with pu-
rified kinase from rabbit reticulocyte lysate and the results
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FIG. 6. Phosphorylating activity of parasite S-100 preparation
and human erythrocyte lysate. (A) Parasite ribosomes, S-100 prep-
aration, the erythrocyte lysate after saponin lysis and release of the
parasite, as well as the final wash of the parasite were all checked for
their ability to phosphorylate the parasite ribosomal proteins. Lane
1, parasite ribosomes plus S-100 preparation; lane 2, parasite ribo-
somes plus buffer A; lane 3, parasite ribosomes plus erythrocyte
lysate; lane 4, parasite ribosomes plus phosphate-buffered saline
wash of the parasite pellet. Incubations were carried out in the
absence of hemin. Molecular mass is indicated in kDa. (B) Parasite
S-100 preparation was incubated in presence (lane 1) and absence
(lane 2) of purified reticulocyte eIF-2 preparation (1 Mg) and phos-
phorylation was carried out as described earlier. The arrow indicates
the position of eIF-2a.
are presented in Fig. 7 A and B. It is interesting to note that
chloroquine at 5 or 10 ,uM has very little effect on autophos-
phorylation of the kinase (Fig. 7A). Hemin at 5 or 10 ttM
inhibits this activity. At equimolar concentrations, chloro-
quine counteracts the effects of hemin but not completely.
Chloroquine at 5 MiM and certainly at 10 MiM stimulates
eIF-2a phosphorylation activity (Fig. 7B). Hemin, as ex-
pected, inhibits eIF-2a phosphorylation and chloroquine at
equimolar concentrations counteracts the effects of hemin
significantly.
DISCUSSION
Evidence for formation of the chloroquine-hemozoin com-
plex in the vacuole in situ is not unequivocal (3, 6) and the
earliest site of lysis due to chloroquine does not appear to be
the vacuolar membrane, although the drug has been sug-
gested to act through this mechanism (7-9). Ginsburg and
Geary (6) suggest that the drug may be directly inhibiting
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FIG. 5. Effect of chloroquine treatment in
situ on parasite eIF-2 phosphorylation in par-
asite lysate. Parasite lysates (S-30) were pre-
pared from control or chloroquine-treated cul-
tures. (A) Phosphorylation of total proteins in
the parasite lysate. (B) Phosphorylation of
eIF-2a in the immunoprecipitate from the
parasite lysate. (C) The eIF-2a region from B
is presented to provide better clarity. Lanes 1,
control lysate (no addition); lanes 2, control
lysate (15 AM hemin); lanes 3, lysate from
chloroquine-treated cultures (no addition);
lanes 4, lysate from chloroquine-treated cul-
tures (15 AM hemin). Blanks run with parasite
lysate from control and chloroquine-treated
cultures with nonimmune serum did not reveal
any phosphorylated band corresponding to
eIF-2a. Molecular mass is indicated in kDa.
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FIG. 7. Effect of hemin and chloroquine on
B purified HRI activity. Autophosphorylation ofHRI (A) and phosphorylation of added eIF-2
1 2 3 4 5 6 7 (0.5 ,.g) (B) were assessed. (A) Lane 1, no
addition; lane 2, chloroquine (5 ,uM); lane 3,
chloroquine (10 MM); lane 4, hemin (5 jLM); lane
5, hemin (10 ,uM); lane 6, hemin plus chloro-
quine (5 LM each); lane 7, hemin plus chloro-
HRI quine (10 jiM each). (B) Lane 1, no addition;
lane 2, chloroquine (5 jiM); lane 3, hemin (5
"AM); lane 4, hemin plus chloroquine (5 AM
each); lane 5, chloroquine (10 AM); lane 6,
_
-ft. at _ _ s-elF-2cm hemin (10 ,uM); lane 7, hemin plus chloroquine(10 AiM each).
membrane phospholipase. Krogstad and Schlesinger (5) have
shown that chloroquine accumulates in the acid vesicles of
the parasite against a concentration gradient and alkalinizes
the vacuole, which may interfere with a variety of processes,
such as receptor-mediated endocytosis, lysosomal enzyme
targeting, and lysosomal enzyme-mediated degradation. As
already indicated, alkalinization as such does not appear to
be sufficient to kill the parasite (6), and in any case the
immediate molecular events following the accumulation of
chloroquine in the parasite vacuole are not clear.
Meshnick (3) has recently suggested that although the Kd
for DNA binding by chloroquine appears very high, it is
possible that 0.03-1% of potential intercalation sites might be
occupied at therapeutic concentrations. Chloroquine has
been found to intercalate more avidly with poly(dG-dC)
polynucleotides than other sequences. At this stage, the
suggestion of preferential binding of the drug to selective G-C
regions of the predominantly (A+T)-rich genome of P. fal-
ciparum remains to be tested but appears farfetched.
The present studies clearly reveal that the parasite shows
heme dependency for protein synthesis just as the reticulo-
cyte lysate. Chloroquine addition in vitro inhibits the heme-
dependent protein synthesis. The basal level of protein
synthesis seen in the absence of added heme may reflect the
extent of functional initiation factor available or the endog-
enous heme that sustains this level of protein synthesis in the
cell-free system may not be accessible to chloroquine. This
may explain the earlier observation, indicating lack of inhi-
bition of cell-free protein synthesis by chloroquine (14). The
parasite lysate from cultures treated with therapeutic con-
centrations of chloroquine in situ for a short period (30 min)
manifests enhanced phosphorylation of eIF-2a under condi-
tions of cell-free protein synthesis, which is inhibited by the
addition of hemin to the lysate. Addition of hemin, phospho-
rylated compounds, and eIF-2, known to counteract the
inhibited protein synthesis in heme-deficient reticulocyte
lysate, has a similar effect with the parasite lysate prepared
from in situ chloroquine-treated cultures. eIF-2a kinase
activity is present in the parasite lysate and is not a contam-
inant derived from the human erythrocytes used for culturing
the parasite. However, further studies are needed to establish
whether the heme-sensitive eIF-2a kinase activity detected in
the parasite lysate is identical or similar to the HRI charac-
terized in reticulocytes. The results presented in Fig. 7 show
that chloroquine prevents inactivation of purified HRI by
heme. This is consistent with the notion that chloroquine
exerts its effects by complexing with heme.
Finally, the enhanced eIF-2a kinase activity seen in par-
asite cultures treated with therapeutic concentrations of
chloroquine for a short period is associated with a decrease
in general protein synthesis. Inhibition of protein synthesis is
thus an early event and is possibly responsible for the other
defects reported, ultimately leading to the death of the
parasite. In this proposed mechanism of action, the avail-
ability of chloroquine and heme at the site of protein syn-
thesis would be the deciding factor, and perhaps accumula-
tion of the antimalarial and the hemozoin pigment in the
parasite vacuole is basically a detoxication mechanism. We
have preliminary evidence to suggest that the parasite syn-
thesizes its own heme, despite the accumulation of the
hemozoin pigment derived from the host hemoglobin.
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